The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy

Bibliografske podrobnosti
Main Authors: Fokas, E, Prevo, R, Reaper, P, Charlton, P, Pollard, J, Mckenna, W, Muschel, R, Brunner, T
Format: Conference item
Izdano: 2012
_version_ 1826281350196363264
author Fokas, E
Prevo, R
Reaper, P
Charlton, P
Pollard, J
Mckenna, W
Muschel, R
Brunner, T
author_facet Fokas, E
Prevo, R
Reaper, P
Charlton, P
Pollard, J
Mckenna, W
Muschel, R
Brunner, T
author_sort Fokas, E
collection OXFORD
description
first_indexed 2024-03-07T00:27:29Z
format Conference item
id oxford-uuid:7ea1020c-b743-407c-abd3-4fcacbd6f6af
institution University of Oxford
last_indexed 2024-03-07T00:27:29Z
publishDate 2012
record_format dspace
spelling oxford-uuid:7ea1020c-b743-407c-abd3-4fcacbd6f6af2022-03-26T21:11:20ZThe novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapyConference itemhttp://purl.org/coar/resource_type/c_5794uuid:7ea1020c-b743-407c-abd3-4fcacbd6f6afSymplectic Elements at Oxford2012Fokas, EPrevo, RReaper, PCharlton, PPollard, JMckenna, WMuschel, RBrunner, T
spellingShingle Fokas, E
Prevo, R
Reaper, P
Charlton, P
Pollard, J
Mckenna, W
Muschel, R
Brunner, T
The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy
title The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy
title_full The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy
title_fullStr The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy
title_full_unstemmed The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy
title_short The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy
title_sort novel atr inhibitor ve 821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy
work_keys_str_mv AT fokase thenovelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT prevor thenovelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT reaperp thenovelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT charltonp thenovelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT pollardj thenovelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT mckennaw thenovelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT muschelr thenovelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT brunnert thenovelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT fokase novelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT prevor novelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT reaperp novelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT charltonp novelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT pollardj novelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT mckennaw novelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT muschelr novelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy
AT brunnert novelatrinhibitorve821selectivelysensitizespancreaticcancercellstoradiationandchemotherapy